FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection

PMA: P230043 · Supplement: S001 · Decision Jul 18, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
Trade Name
Cologuard Plus™
PMA Number
P230043
Supplement Number
S001
Device Class
FDA Class 3
Product Code
PHP
Generic Name
System, colorectal neoplasia, DNA methylation and hemoglobin detection
Medical Specialty
Unknown
Advisory Committee
Pathology
Decision
Approved
Decision Code
APPR
Decision Date
July 18, 2025
Date Received
April 25, 2025
Supplement Type
Real-Time Process
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval of a labeling change affecting two PMAs Cologuard (P130017) and Cologuard Plus (P230043), to introduce a new "Dual Labeled Cologuard Collection Kit" that can be used with both Cologuard (P130017) and Cologuard Plus (P230043).

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PHP System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection